Gain Nsclc Summit: Houston

Things to do
Gain Nsclc Summit: Houston
More Less
Gain Nsclc Summit: Houston says
Engaging an Interdisciplinary Team for NSCLC Diagnosis, Personalized Assessment, and Treatment (GAIN) is an innovative longitudinal educational initiative consisting of pulmonology, thoracic surgery, pathology, and oncology clinicians engaged in various live, enduring, and practice improvement efforts.

This educational curriculum is designed for health-care providers to improve their knowledge, skills, and competence in the assessment and management of non-small cell lung cancer (NSCLC).

Content will address management of locally advanced and metastatic lung cancer by using multidisciplinary and multimodality approaches. These include conventional chemotherapy and biomarker-driven therapy, including immune checkpoint inhibitors that target to unleash or enhance preexisting anticancer immune responses. Examples of these immunotherapies target PD-1 antibodies, PD-L1 antibodies, and CTLA-4 antibodies. Genotype-driven therapy will be addressed by discussing agents that target genetic abnormalities, including but not limited to: EGFR, KRAS, BRAF mutations, and ALK and ROS1 translocations.

GAIN Live Summits feature an experiential learning theory-based instructional design with pre-course learning activities, flipped classroom, and interactive, participatory group and team-based workshop sessions.

This initiative will engage the following health-care professional audiences who focus on NSCLC diagnosis and patient care:

- Pulmonology
- Thoracic Surgery
- Pathology
- Medical Oncology
- Relevant Physician Assistants and Nurse Practitioners
- Nurse Navigators and Case Managers
More Less

By: American College of Chest Physicians